ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C

Збережено в:
Бібліографічні деталі
Дата:2015
Автори: A. Kucherenko, V. Pampukha, I. Bobrova, L. Moroz, L. Livshits
Формат: Стаття
Мова:Англійська
Опубліковано: 2015
Назва видання:Cytology and genetics
Онлайн доступ:http://jnas.nbuv.gov.ua/article/UJRN-0000683039
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Library portal of National Academy of Sciences of Ukraine | LibNAS

Репозитарії

Library portal of National Academy of Sciences of Ukraine | LibNAS
_version_ 1859525743996829696
author A. Kucherenko
V. Pampukha
I. Bobrova
L. Moroz
L. Livshits
author_facet A. Kucherenko
V. Pampukha
I. Bobrova
L. Moroz
L. Livshits
author_sort A. Kucherenko
collection Open-Science
first_indexed 2025-07-22T04:54:20Z
format Article
id open-sciencenbuvgovua-65168
institution Library portal of National Academy of Sciences of Ukraine | LibNAS
language English
last_indexed 2025-07-22T04:54:20Z
publishDate 2015
record_format dspace
series Cytology and genetics
spelling open-sciencenbuvgovua-651682024-04-16T13:16:27Z ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C A. Kucherenko V. Pampukha I. Bobrova L. Moroz L. Livshits 0564-3783 2015 en Cytology and genetics http://jnas.nbuv.gov.ua/article/UJRN-0000683039 Article
spellingShingle Cytology and genetics
A. Kucherenko
V. Pampukha
I. Bobrova
L. Moroz
L. Livshits
ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C
title ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C
title_full ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C
title_fullStr ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C
title_full_unstemmed ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C
title_short ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C
title_sort itpa gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in ukrainian patients with chronic hepatitis c
url http://jnas.nbuv.gov.ua/article/UJRN-0000683039
work_keys_str_mv AT akucherenko itpagenevariantmayprotectagainstanemiainducedduringpegylatedinterferonalfaandribavirincombinationtreatmentinukrainianpatientswithchronichepatitisc
AT vpampukha itpagenevariantmayprotectagainstanemiainducedduringpegylatedinterferonalfaandribavirincombinationtreatmentinukrainianpatientswithchronichepatitisc
AT ibobrova itpagenevariantmayprotectagainstanemiainducedduringpegylatedinterferonalfaandribavirincombinationtreatmentinukrainianpatientswithchronichepatitisc
AT lmoroz itpagenevariantmayprotectagainstanemiainducedduringpegylatedinterferonalfaandribavirincombinationtreatmentinukrainianpatientswithchronichepatitisc
AT llivshits itpagenevariantmayprotectagainstanemiainducedduringpegylatedinterferonalfaandribavirincombinationtreatmentinukrainianpatientswithchronichepatitisc